NasdaqCM - Nasdaq Real Time Price USD
Rein Therapeutics Inc. (RNTX)
1.7600
+0.0200
+(1.15%)
At close: May 9 at 4:00:00 PM EDT
1.7600
0.00
(0.00%)
After hours: May 9 at 4:05:07 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 32.99k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| WINDSOR JAMES BRIAN Chief Executive Officer | Purchase at price 2.24 - 2.25 per share. | Indirect | 898 | Dec 5, 2024 |
| UNIVERSITY OF TEXAS INVESTMENT MANAGEMENT Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.25 - 3.30 per share. | Direct | 21,568 | Jun 17, 2024 |
| UNIVERSITY OF TEXAS INVESTMENT MANAGEMENT Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.25 - 3.35 per share. | Direct | 80,710 | Jun 12, 2024 |
| UNIVERSITY OF TEXAS INVESTMENT MANAGEMENT Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.25 - 3.30 per share. | Direct | 40,528 | Jun 7, 2024 |
| UNIVERSITY OF TEXAS INVESTMENT MANAGEMENT Beneficial Owner of more than 10% of a Class of Security | Sale at price 4.10 - 5.02 per share. | Direct | 139,103 | May 1, 2024 |
| UNIVERSITY OF TEXAS INVESTMENT MANAGEMENT Beneficial Owner of more than 10% of a Class of Security | Sale at price 4.10 - 4.32 per share. | Direct | 85,473 | May 1, 2024 |
| WINDSOR JAMES BRIAN President | -- | Direct | -- | Mar 5, 2024 |
| WINDSOR JAMES BRIAN President | Purchase at price 3.37 per share. | Indirect | 758 | Dec 15, 2023 |
| WINDSOR JAMES BRIAN President | Purchase at price 1.97 per share. | Direct | 9,987 | Nov 20, 2023 |
Related Tickers
ACTU Actuate Therapeutics, Inc. Common stock
10.35
+4.55%
RNXT RenovoRx, Inc.
1.0600
+1.92%
CUE Cue Biopharma, Inc.
0.7797
+1.52%
COYA Coya Therapeutics, Inc.
6.05
-2.58%
INAB IN8bio, Inc.
0.1574
-6.25%
NMTRQ 9 Meters Biopharma, Inc.
0.0001
0.00%
4565.T Nxera Pharma Co., Ltd.
858.00
-2.05%
4587.T PeptiDream Inc.
1,890.50
-1.36%
APS.TO Aptose Biosciences Inc.
2.2100
-0.45%
APTOF Aptose Biosciences Inc.
1.6500
0.00%